Alector, Inc. (NASDAQ:ALEC) Financial and Operational Highlights

Alector reported a quarterly loss of $0.34 per share, surpassing the expected loss with a 13.71% earnings surprise.The company's revenue for the quarter was $6.24 million, significantly exceeding expectations by 103.43%.Alector's financial position is bolstered by $256 million in cash and equivalents, with a current ratio of 3.83, indicating a strong ability to cover short-term liabilities.Alector, Inc. (NASDAQ:ALEC) is a clinical-stage biotechnology company focused on developing therapies for neurodegenera ...